{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T15:38:39Z","timestamp":1649086719233},"reference-count":8,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,3,10]]},"DOI":"10.1182\/blood-2016-01-687681","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T12:34:35Z","timestamp":1457613275000},"page":"1224-1225","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Allogeneic CAR19 cells clear ALL"],"prefix":"10.1182","volume":"127","author":[{"given":"Paul","family":"Neeson","sequence":"first","affiliation":[{"name":"PETER MACCALLUM CANCER CENTER"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111902402804200_B1","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2015-08-664250","article-title":"Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD.","author":"Jacoby","year":"2016","journal-title":"Blood"},{"issue":"25","key":"2019111902402804200_B2","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood-2013-08-519413","article-title":"Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.","volume":"122","author":"Kochenderfer","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2019111902402804200_B3","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/PPO.0000000000000153","article-title":"CD19-targeted T cells for hematologic malignancies: clinical experience to date.","volume":"21","author":"Davila","year":"2015","journal-title":"Cancer J"},{"issue":"2","key":"2019111902402804200_B4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome.","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"issue":"12","key":"2019111902402804200_B5","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.bbmt.2011.07.001","article-title":"Tocilizumab for the treatment of steroid refractory graft-versus-host disease.","volume":"17","author":"Drobyski","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"2019111902402804200_B6","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.2046.2046","article-title":"First clinical application of talen engineered universal CAR19 T cells in B-ALL [abstract].","volume":"126","author":"Qasim","year":"2015","journal-title":"Blood"},{"issue":"18","key":"2019111902402804200_B7","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2013-11-541235","article-title":"Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy.","volume":"124","author":"Heczey","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2019111902402804200_B8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/mt.2012.267","article-title":"Bispecific T-cells expressing polyclonal repertoire of endogenous \u03b3\u03b4 T-cell receptors and introduced CD19-specific chimeric antigen receptor.","volume":"21","author":"Deniger","year":"2013","journal-title":"Mol Ther"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/10\/1224\/1391535\/1224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/10\/1224\/1391535\/1224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:42:31Z","timestamp":1574131351000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/127\/10\/1224\/34931\/Allogeneic-CAR19-cells-clear-ALL"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,10]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,3,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-01-687681","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,10]]}}}